Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
D02CQL
|
|||
Former ID |
DIB007238
|
|||
Drug Name |
Adyvia
|
|||
Synonyms |
ID 1101
Click to Show/Hide
|
|||
Drug Type |
Small molecular drug
|
|||
Indication | Type-2 diabetes [ICD-11: 5A11; ICD-9: 250] | Discontinued in Phase 2 | [1] | |
Company |
Innodia
|
|||
Structure |
Download2D MOL |
|||
Formula |
C6H13NO3
|
|||
Canonical SMILES |
CC(C(C)O)C(C(=O)O)N
|
|||
InChI |
1S/C6H13NO3/c1-3(4(2)8)5(7)6(9)10/h3-5,8H,7H2,1-2H3,(H,9,10)/t3-,4-,5-/m0/s1
|
|||
InChIKey |
OSCCDBFHNMXNME-YUPRTTJUSA-N
|
|||
CAS Number |
CAS 55399-93-4
|
|||
PubChem Compound ID | ||||
PubChem Substance ID | ||||
ChEBI ID |
CHEBI:78247
|
References | Top | |||
---|---|---|---|---|
REF 1 | Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800018893) | |||
REF 2 | Insulinotropic agent ID-1101 (4-hydroxyisoleucine) activates insulin signaling in rat.Am J Physiol Endocrinol Metab.2004 Sep;287(3):E463-71. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.